Azienda Ospedaliera San Gerardo di Monza
Also known as: AO San Gerardo Monza, Italy | AO San Gerardo of Monza | ASST Monza | Azienda Ospedaliera San Gerardo di Monza | Azienda Ospedaliera San Gerardo di Monza U.O. Ematologia | Azienda Ospedaliera San Gerardo Monza | Azienda Ospedaliera San Gerardo, Monza,Italy | Centro Studi e Ricerca in Medicina Generale, Monza, Italy | Dipartimento di Emergenza Urgenza, Azienda Ospedaliera San Gerardo, Monza,Italy | Ettore Biagi, MD | Ospedale di Monza | Ospedale San Gerardo di Monza | Ospedale San Gerardo Monza | Ospedale San Gerardo - Monza (MI) | Ospedale S. Gerardo - Monza | Ospedale S. Gerardo, Monza
Highest phase reached
Phase 4
First clinical trial
Feb 1, 2004Last known activity
Nov 30, 2021
Timeline
1980s
- Jan 1, 1980
Azienda Ospedaliera San Gerardo di Monza— Founded
Drugs by trial phase (52 distinct, 24 trials)
Phase 4 (15 own, 0 via acquisition)
Phase 3 (18 own, 0 via acquisition)
Phase 2 (16 own, 0 via acquisition)
Phase 1 (2 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Studied for
- Breast Neoplasms
- Carcinoma
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Renal Cell
- Cardiovascular Diseases
- Cognitive Dysfunction
- Epilepsies, Partial
- Epilepsy
- Graft vs Host Disease
- Hemorrhage
- Infarction
- Leukemia
- Leukemia, Lymphocytic, Chronic, B-Cell
- Leukemia, Lymphoid
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
- Lung Neoplasms
- Mesothelioma
- Metal Metabolism, Inborn Errors
- Myocardial Infarction
- Nausea
- Neoplasm Metastasis
- Neoplasms
- Philadelphia Chromosome
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- ST Elevation Myocardial Infarction
- Subarachnoid Hemorrhage
- Triple Negative Breast Neoplasms
- Vomiting
Recent trials (35)
- NCT05014581Lead sponsorPhase 3Nov 30, 2021
- NCT05014581Reponsible party - principal investigatorPhase 3Nov 30, 2021
- NCT04979468Overall official - principal investigatorPhase 3Mar 23, 2021
- NCT04709731Overall official - principal investigatorPhase 2Feb 1, 2021
- NCT04303377CollaboratorPhase 2Nov 18, 2019
- NCT03689114CollaboratorPhase 4Jan 31, 2019
- NCT03358004Overall official - principal investigatorPhase 2Oct 30, 2017
- NCT02482766CollaboratorN/ANov 1, 2015
- NCT02428062Study chairPhase 2/Phase 3Oct 1, 2014
- NCT02042001Study directorPhase 4Apr 1, 2014
- NCT02042001Overall official - principal investigatorPhase 4Apr 1, 2014
- NCT02042001Lead sponsorPhase 4Apr 1, 2014
- NCT02042001Reponsible party - principal investigatorPhase 4Apr 1, 2014
- NCT02059681CollaboratorPhase 1Dec 31, 2013
- NCT02194231Overall official - principal investigatorPhase 2Jul 1, 2013
Details
- Founded
- Monza, IT Jan 1, 1980
- Last known activity
- Nov 30, 2021